Affiliation:
1. V.A. Nasonova Research Institute of Rheumatology
Abstract
The modern strategy for the treatment of rheumatic diseases (RD) involves the fastest possible achievement of remission or low disease activity. However, even with the use of the most modern technologies and after a pronounced decrease in the inflammatory activity of the disease, it is not always possible to achieve a complete and stable remission. In such a situation, an important goal of treatment is to maximize the quality of life (QoL) of patients. Pain is one of the leading predictors of a decrease in QoL in patients with RD. At the same time, effective pain control can improve not only the course of individual symptoms of the disease, but also life prognosis as a whole. Non-steroidal anti-inflammatory drugs (NSAIDs) are the most popular drugs for the symptomatic treatment of RD. At the same time, the administration of NSAIDs with a favorable safety profile can improve the quality of life of patients. Meloxicam is the first predominantly selective inhibitor of cyclooxygenase (COX) 2, which appeared in the arsenal of practitioners in the late 90s and has a strong evidence base for efficacy and safety.
Subject
Pharmacology (medical),Immunology,Immunology and Allergy,Rheumatology
Reference31 articles.
1. Nasonov EL, editor. Rossiiskie klinicheskie rekomendatsii. Revmatologiya [Russian clinical guidelines. Rheumatology]. Moscow: GEOTAR-Media; 2020. 448 p.
2. Lila AM, Alekseeva LI, Taskina EA. Modern approaches to the treatment of osteoarthritis taking into account the updated international recommendations. Russkii meditsinskii zhurnal. 2019;3(11):48-52. (In Russ.).
3. Pincus T, Castrejon I, Yazici Y, et al. Osteoarthritis is as severe as rheumatoid arthritis: evidence over 40 years according to the same measure in each disease. Clin Exp Rheumatol. Sep-Oct 2019;37 Suppl 120(5):7-17. Epub 2019 Oct 14.
4. Amirdzhanova VN, Goryachev DV, Korshunov NI, et al. Population indicators of quality of life according to the SF-36 questionnaire (results of the multicenter study of quality of life «MIRAGE»). Nauchcno-Prakticheskaya Revmatologia. 2008;46(1):36-48. (In Russ.).
5. Sprangers MA, de Regt EB, Andries F, et al. Which chronic conditions are associated with better or poorer quality of life? J Clin Epidemiol. 2000 Sep;53(9):895-907. doi: 10.1016/s0895-4356(00)00204-3.